XNYS:MRX Insider Activity 3 Filing - 1/1/2012

Effective Date 1/1/2012

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  RODNER SETH L
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2012
3. Issuer Name and Ticker or Trading Symbol
MEDICIS PHARMACEUTICAL CORP [MRX]
(Last)
(First)
(Middle)
7720 N. DOBSON RD.
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
EVP, CLO & Corp Secretary
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)

SCOTTSDALE, AZ 85256
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 24,090(1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Appreciation Right   (2) 02/27/2016 Common Stock 112,701 $11.28 D  
Employee Stock Appreciation Right   (3) 03/01/2017 Common Stock 83,382 $22.69 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
RODNER SETH L
7720 N. DOBSON RD.
SCOTTSDALE, AZ 85256
      EVP, CLO & Corp Secretary  

Signatures

Seth L. Rodner 01/11/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents shares of restricted stock.
(2) The Stock Appreciation Right ("SAR") vests in five (5) annual installments on each anniversary of the Grant Date as follows: Year 1, 10%; Year 2, 10%; Year 3, 20%; Year 4, 30%; Year 5, 30%. Upon exercise, the vested SARs will be settled in cash. The SAR was granted on 02/27/2009 (the "Grant Date"). The amount shown in column 3 represents the number of shares of common stock of the Issuer underlying the SAR which remains unvested. No vested portion of the SAR remains unexercised as of the date hereof.
(3) The Stock Appreciation Right ("SAR") vests in five (5) annual installments on each anniversary of the Grant Date as follows: Year 1, 10%; Year 2, 10%; Year 3, 20%; Year 4, 30%; Year 5, 30%. Upon exercise, the vested SARs will be settled in cash. The SAR was granted on 03/01/2010 (the "Grant Date"). The amount shown in column 3 represents the number of shares of common stock of the Issuer underlying the SAR which remains unvested. No vested portion of the SAR remains unexercised as of the date hereof.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

XNYS:MRX Insider Activity 3 Filling

XNYS:MRX Stock - Get Insider Activity SEC Filing of XNYS:MRX stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNYS:MRX Insider Activity 3 Filing - 1/1/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNYS:MRH Montpelier RE Holdings Ltd Quarterly Report 10-Q Filing - 6/30/2012  |  Next: XNYS:MRX Insider Activity 4 Filing - 10/1/2012